(Q45393348)

14 December 2017

title

Hemodynamic effects of alinidine (ST 567) at rest and during exercise in patients with chronic congestive heart failure (English)

1 reference

14 December 2017

main subject

congestive heart failure

1 reference

1

Koenig W

1 reference

14 December 2017

Stauch M

2

1 reference

14 December 2017

Sund M

series ordinal

3

1 reference

14 December 2017

Wanjura D

series ordinal

4

1 reference

14 December 2017

Henze E

series ordinal

5

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 June 1990

1 reference

14 December 2017

published in

American Heart Journal

1 reference

14 December 2017

volume

119

1 reference

14 December 2017

issue

6

1 reference

14 December 2017

page(s)

1348-1354

1 reference

Medical treatment of ischaemic heart disease--beta-blockers

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

A randomized study comparing propranolol and diltiazem in the treatment of unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

N-Allyl-derivative of clonidine, a substance with specific bradycardic action at a cardiac site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Clinical Electrophysiological Properties of N-Allyl-Clonidine (ST 567) in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

New aspects in the metabolism of alinidine in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Alinidine pharmacokinetics following acute and chronic dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Pharmacokinetics and metabolism of14C-labelled alinidine in man an dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Alinidine reduces heart-rate without blockade of beta-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Haemodynamic effects of alinidine, a specific sinus node inhibition, in patients with unstable angina or myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Left ventricular stroke volume determinations from radionuclide ventriculograms: the effects of photon attenuation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Systemic and regional myocardial responses to AR-L 115 BS, a positive inotropic imidazo-pyridine, in the absence or in the presence of the bradycardiac action of alinidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

Central α-adrenergic systems as targets for hypotensive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980185-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(05)80185-1

1 reference

14 December 2017

1 reference